Cognizant and TransCelerate BioPharma have joined forces to create the Shared Investigator Platform, which will accelerate the developments of new medicines.
SIP is a cloud-based, open architecture platform that supports common research and clinical trial requirements for the biopharmaceutical industry. The companies hope the platform will streamline collaboration and provide a focal point for trial sponsors, clinical researchers, investigators and eventually regulators.
More articles on health IT:
Oracle releases cloud-based eClinical platform
Lafayette General Health to use $250k grant to expand telemedicine in local public schools